IP Library Granted Patent US 12,702,833
Granted Patent B2
US 12,702,833 · App. 17/718,026 · Granted Aug 11, 2026

Head worn apparatuses for vision therapy

Inventors: Paul Rockley (Corona Del Mar, CA); James R. Chiapetta (Delano, MN); Thomas W. Harold (Prior Lake, MN); Michael Ashker (Gold River, CA)
Assignee: i-Lumen Scientific, Inc.
A61N1/36046A61N1/0408A61N1/0484A61N1/36014
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,702,833
App. No.
17/718,026
Granted
Aug 11, 2026
Kind
B2
Abstract

Systems, devices, and methods for use in delivering stimulation to the head of a patient, including examples directed to delivering electrical or other stimulation to the eye of the patient. In some examples eyepieces or eyepatches are configured to deliver electrical or other stimulus to the eye of a patient by being worn on the face of the patient.

Claims (45)

1 . A patient interface apparatus for delivery of stimulus to a portion of the head of a patient for a session, the patient interface apparatus comprising:

a first eyepiece adapted to fit about at least one eye of the patient;

wherein the first eyepiece comprises at least first and second electrodes, the first eyepiece further comprising at least first and second electrical connectors separately coupled to the first and second electrodes;

wherein the patient interface apparatus further comprises a pulse generator coupled to at least the first and second electrical connectors to issue electrical therapy pulses using the first and second electrodes; and

wherein the pulse generator is configured to:

monitor a tissue impedance between the first and second electrodes before commencement of the electrical therapy to establish an initial impedance-based threshold for the patient;

define a session-specific acceptable impedance upper limit on the basis of the initial threshold;

compare a subsequently monitored tissue impedance to the session-specific acceptable impedance upper limit; and

interrupt or withhold the electrical therapy when the subsequently monitored tissue impedance exceeds the session-specific acceptable impedance upper limit.

2 . The patient interface apparatus of claim 1 , further comprising a frame or a strap to hold the first eyepiece on the head of the patient, wherein the first eyepiece is configured to hold the first electrode on the patient's eyelid.

3 . The patient interface apparatus of claim 1 wherein the first eyepiece is a closed eyepiece having a transparent portion through which the patient can see while wearing the first eyepiece.

4 . The patient interface apparatus of claim 1 , wherein the pulse generator is configured to issue therapy pulses by using the first and second electrodes of the first eyepiece as opposing electrodes.

5 . The patient interface apparatus of claim 4 , wherein the first and second electrodes are positioned on the eyepiece above and below the transparent portion.

6 . The patient interface apparatus of claim 4 , wherein the first and second electrodes are positioned on the eyepiece below the transparent portion.

7 . The patient interface apparatus of claim 4 , wherein the pulse generator is configured to issue the therapy pulses using the first and second electrodes of the first eyepiece as opposing electrodes without a separate return electrode.

8 . The patient interface apparatus of claim 1 , further comprising a second eyepiece adapted to fit about at least one eye of the patient and including at least third and fourth electrodes, the second eyepiece further comprising at least third and fourth electrical connectors separately coupled to the third and fourth electrodes, wherein the pulse generator is coupled to the third and fourth electrical connectors to issue therapy pulses from the third and fourth electrodes.

9 . The patient interface apparatus of claim 8 , wherein the pulse generator is configured to issue therapy pulses using the first and second electrodes together as one of anode or cathode, and using the third and fourth electrodes together in electrical opposition to the first and second electrodes.

10 . A method of treating a patient having a vision disorder comprising:

having the patient wear a patient interface apparatus for a session comprising:

(i) a first eyepiece adapted to fit about at least one eye of the patient, wherein the first eyepiece comprises at least first and second electrodes, the first eyepiece further comprising at least first and second electrical connectors separately coupled to the first and second electrodes, and

(ii) a pulse generator coupled to at least the first and second electrical connectors to issue therapy pulses using the first and second electrodes; and

activating the pulse generator to issue an electrical therapy to the eye using the first and second electrodes as a series of electrical therapy pulses;

monitoring a tissue impedance between the first and second electrodes before commencement of the electrical therapy to establish an initial impedance-based threshold for the patient;

defining a session-specific acceptable impedance upper limit on the basis of the initial threshold;

comparing a subsequently monitored tissue impedance to the session-specific acceptable impedance upper limit; and

interrupting or withholding the electrical therapy when the subsequently monitored tissue impedance exceeds the session-specific acceptable impedance upper limit.

11 . The method of claim 10 , wherein the patient interface apparatus further comprises a frame or a strap to hold the first eyepiece on the head of the patient, and wherein the first eyepiece is a closed eyepiece having a transparent portion through which the patient can see while wearing the first eyepiece and receiving electrical therapy.

12 . The method of claim 10 , wherein the step the pulse generator issuing the electrical therapy comprises the pulse generator using the first and second electrodes of the first eyepiece as opposing electrodes.

13 . The method of claim 12 , wherein the first and second electrodes are positioned above and below the eye.

14 . The method of claim 12 , wherein the first and second electrodes are positioned below the eye.

15 . The method of claim 12 , wherein the pulse generator using the first and second electrodes of the first eyepiece as opposing electrodes is performed without the use of a separate return electrode.

16 . The method of claim 10 , wherein the patient interface apparatus includes a second eyepiece adapted to fit about at least one eye of the patient and including at least third and fourth electrodes, the second eyepiece further comprising at least third and fourth electrical connectors separately coupled to the third and fourth electrodes, wherein the pulse generator is coupled to the third and fourth electrical connectors to issue therapy pulses from the third and fourth electrodes.

17 . The method of claim 16 , wherein the step of the pulse generator issuing the electrical therapy as a series of electrical therapy pulses comprises using the first and second electrodes together as one of anode or cathode, and using one or more return electrodes in electrical opposition to the first and second electrodes.

18 . The patient interface apparatus of claim 1 , further comprising one or more return electrodes.

19 . The patient interface apparatus of claim 18 , wherein the one or more return electrodes are coupled to an earpiece of the frame.

20 . The patient interface apparatus of claim 18 , wherein the impedance of the at least one of the first and second electrodes is measured relative to the one or more return electrodes.

21 . The patient interface apparatus of claim 20 , wherein the pulse generator is further configured to determine tissue-electrode contact quality by selectively enabling one of the first and second electrodes while disabling the other, and measuring impedance between the enabled electrode and the one or more return electrodes.

22 . The patient interface apparatus of claim 20 , wherein the pulse generator is configured to perform differential impedance measurements by measuring impedance between each of the first and second electrodes and the one or more return electrodes, and comparing the measured impedances to one another to identify which electrode has inadequate tissue contact.

23 . The patient interface apparatus of claim 20 , wherein the pulse generator is configured to confirm tissue contact at the first and second electrodes by performing localized impedance tests between the first and second electrodes without referencing the one or more return electrodes, and using results of the localized impedance tests in conjunction with impedance measurements relative to the one or more return electrodes to distinguish whether high impedance is caused by one of the first and second electrodes or by the one or more return electrodes.

24 . The patient-interface apparatus of claim 20 , further comprising a third electrode, wherein the pulse generator is configured to deliver a diagnostic test stimulus between at least one of the first and second electrodes and the one or more return electrodes while sensing an electrical response at the third electrode to determine tissue-electrode contact quality prior to or during the electrical therapy.

25 . The patient-interface apparatus of claim 1 , wherein the pulse generator is configured to deliver a low-amplitude diagnostic pulse, distinct from the electrical therapy pulses, to obtain the initial tissue-impedance measurement and to refrain from issuing the electrical therapy pulses until the measured tissue impedance is below the session-specific acceptable impedance upper limit.

26 . The patient-interface apparatus of claim 1 , wherein the pulse generator is further configured to monitor the tissue impedance at predetermined intervals during the sequence of electrical therapy pulses, dynamically update the session-specific acceptable impedance upper limit in accordance with changes in the monitored impedance, and interrupt the electrical therapy when the monitored impedance falls outside the updated upper limit.

27 . The patient-interface apparatus of claim 1 , wherein the pulse generator is configured to: define a session-specific acceptable impedance range including the upper limit on the basis of the initial threshold; compare a subsequently monitored tissue impedance to the session-specific acceptable impedance range; and interrupt or withhold the electrical therapy when the subsequently monitored tissue impedance lies outside the session-specific acceptable impedance range.

28 . The patient-interface apparatus of claim 1 , wherein the pulse generator is further configured to determine if the initial threshold is within an acceptable range.

29 . The patient interface apparatus of claim 1 , wherein the pulse generator is configured to issue therapy pulses using the first and second electrodes together as one of anode or cathode, and using one or more return electrodes in electrical opposition to the first and second electrodes.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE FROM "BIOVISICS MEDICAL, LLC" TO "BIOVISICS MEDICAL, INC" PREVIOUSLY RECORDED AT REEL: 69331 FRAME: 698. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Feb 28, 2025
From: BIOVISICS MEDICAL, LLC
To: BIOVISICS MEDICAL, INC.
Reel/Frame 071406/0716 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2024
From: ROCKLEY, PAUL; CHIAPETTA, JAMES R.; HAROLD, THOMAS W.; ASHKER, MICHAEL
To: BIOVISICS MEDICAL, LLC
Reel/Frame 069331/0372 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2024
From: BIOVISICS MEDICAL, INC.
To: I-LUMEN SCIENTIFIC, INC.
Reel/Frame 069328/0209 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2024
From: BIOVISICS MEDICAL, LLC
To: BIOVISICS MEDICAL, LLC
Reel/Frame 069331/0698 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2024
From: BIOVISICS MEDICAL, INC.
To: I-LUMEN SCIENTIFIC, INC.
Reel/Frame 069227/0719 →
Continuity (3)
Continuation 16697689 · Nov 27, 2019
Provisional Application 62774093 · Nov 30, 2018
Related Publication 20220305265A1 · Sep 29, 2022
References Cited (255)
US 2283752A · Gonsett · 1942 [cited by applicant]
US 2527947A · Loos · 1950 [cited by applicant]
US 2760483A · Tassicker · 1956 [cited by applicant]
US 3376870A · Yamamoto · 1968 [cited by examiner]
US 3669119A · Symmes · 1972 [cited by applicant]
US D246529S · Willard · 1977 [cited by applicant]
US 4162542A · Frank · 1979 [cited by applicant]
US D280670S · Fireman · 1985 [cited by applicant]
US 4551149A · Scairra · 1985 [cited by applicant]
US 4614193A · Liss et al. · 1986 [cited by applicant]
US 4628933A · Michelson · 1986 [cited by applicant]
US 4664117A · Beck · 1987 [cited by applicant]
US 4712558A · Kidd et al. · 1987 [cited by applicant]
US 4979811A · Boyer · 1990 [cited by applicant]
US 5024223A · Chow · 1991 [cited by applicant]
US 5109844A · De Juan et al. · 1992 [cited by applicant]
US 5147284A · Fedorov et al. · 1992 [cited by applicant]
US 5154174A · Hawlina · 1992 [cited by applicant]
US 5193540A · Schulman et al. · 1993 [cited by applicant]
US 5263200A · Miller · 1993 [cited by applicant]
US 5522864A · Wallace et al. · 1996 [cited by applicant]
US 5556423A · Chow et al. · 1996 [cited by applicant]
US 5597381A · Rizzo, III · 1997 [cited by applicant]
US 5643330A · Holsheimer et al. · 1997 [cited by applicant]
US 5836996A · Doorish · 1998 [cited by applicant]
US 5843147A · Testerman et al. · 1998 [cited by applicant]
US 5865839A · Doorish · 1999 [cited by applicant]
US 5873901A · Wu et al. · 1999 [cited by applicant]
US 5895415A · Chow et al. · 1999 [cited by applicant]
US 5935155A · Humayun et al. · 1999 [cited by applicant]
US 5944747A · Greenberg et al. · 1999 [cited by applicant]
US 6007532A · Netherly · 1999 [cited by applicant]
US D421124S · Yavitz · 2000 [cited by applicant]
US 6035236A · Jarding et al. · 2000 [cited by applicant]
US D425623S · Funk · 2000 [cited by applicant]
US D429817S · Banks · 2000 [cited by applicant]
US 6101411A · Newsome · 2000 [cited by applicant]
US 6131208A · Banks · 2000 [cited by applicant]
US 6154671A · Parel et al. · 2000 [cited by applicant]
US D440660S · Sternberg · 2001 [cited by applicant]
US 6230057B1 · Chow et al. · 2001 [cited by applicant]
US D444561S · Stein · 2001 [cited by applicant]
US 6275735B1 · Jarding et al. · 2001 [cited by applicant]
US 6282449B1 · Kamerling et al. · 2001 [cited by applicant]
US 6306075B1 · Shadduck · 2001 [cited by applicant]
US 6324429B1 · Shire et al. · 2001 [cited by applicant]
US 6389317B1 · Chow et al. · 2002 [cited by applicant]
US 6400989B1 · Eckmiller · 2002 [cited by applicant]
US 6408211B1 · Powell · 2002 [cited by applicant]
US 6424864B1 · Matsuura · 2002 [cited by applicant]
US 6442431B1 · Veraart et al. · 2002 [cited by applicant]
US 6458157B1 · Suaning · 2002 [cited by applicant]
US 6515227B1 · Massey et al. · 2003 [cited by applicant]
US 6611716B2 · Chow et al. · 2003 [cited by applicant]
US 6755530B1 · Loftus et al. · 2004 [cited by applicant]
US 6792314B2 · Byers et al. · 2004 [cited by applicant]
US 6976998B2 · Rizzo et al. · 2005 [cited by applicant]
US 6990377B2 · Gliner et al. · 2006 [cited by applicant]
US 7001608B2 · Fishman et al. · 2006 [cited by applicant]
US 7003354B2 · Chow et al. · 2006 [cited by applicant]
US 7006873B2 · Chow et al. · 2006 [cited by applicant]
US 7031776B2 · Chow et al. · 2006 [cited by applicant]
US 7037943B2 · Peyman · 2006 [cited by applicant]
US 7043308B2 · Cohen · 2006 [cited by applicant]
US 7047080B2 · Palanker et al. · 2006 [cited by applicant]
US 7058455B2 · Huie, Jr. et al. · 2006 [cited by applicant]
US 7067327B2 · Wu et al. · 2006 [cited by applicant]
US 7130693B1 · Montalbo · 2006 [cited by applicant]
US 7139612B2 · Chow et al. · 2006 [cited by applicant]
US 7146209B2 · Gross et al. · 2006 [cited by applicant]
US 7147865B2 · Fishman et al. · 2006 [cited by applicant]
US 7158834B2 · Paul, Jr. · 2007 [cited by applicant]
US 7158836B2 · Suzuki · 2007 [cited by applicant]
US 7248928B2 · Yagi · 2007 [cited by applicant]
US 7251528B2 · Harold · 2007 [cited by applicant]
US 7306621B1 · Halla et al. · 2007 [cited by applicant]
US 7321796B2 · Fink et al. · 2008 [cited by applicant]
US 7337008B2 · Terasawa et al. · 2008 [cited by applicant]
US 7398124B2 · Fujikado et al. · 2008 [cited by applicant]
US 7400021B2 · Wu et al. · 2008 [cited by applicant]
US 7447547B2 · Palanker · 2008 [cited by applicant]
US 7447548B2 · Eckmiller · 2008 [cited by applicant]
US 7458456B2 · Hogan et al. · 2008 [cited by applicant]
US 7556621B2 · Palanker et al. · 2009 [cited by applicant]
US 7877148B2 · Chowdhury et al. · 2011 [cited by applicant]
US 7883535B2 · Cantin et al. · 2011 [cited by applicant]
US 7974699B2 · Tano et al. · 2011 [cited by applicant]
US 7979134B2 · Chow et al. · 2011 [cited by applicant]
US 7981062B2 · Chow et al. · 2011 [cited by applicant]
US 8000804B1 · Wessendorf et al. · 2011 [cited by applicant]
US 8039445B2 · Behar-Cohen et al. · 2011 [cited by applicant]
US 8070688B2 · Livne et al. · 2011 [cited by applicant]
US 8190266B2 · Ameri et al. · 2012 [cited by applicant]
US 8197539B2 · Nasiatka et al. · 2012 [cited by applicant]
US 8260428B2 · Fink et al. · 2012 [cited by applicant]
US 8265764B2 · Tano et al. · 2012 [cited by applicant]
US 8306626B2 · Chow et al. · 2012 [cited by applicant]
US 8377120B2 · Lipshitz et al. · 2013 [cited by applicant]
US 8396561B2 · Pezaris et al. · 2013 [cited by applicant]
US 8396562B2 · Ameri et al. · 2013 [cited by applicant]
US 8398692B2 · Deisseroth et al. · 2013 [cited by applicant]
US 8433417B2 · Flood · 2013 [cited by applicant]
US 8478415B1 · Halla et al. · 2013 [cited by applicant]
US 8515548B2 · Rofougaran et al. · 2013 [cited by applicant]
US 8612002B2 · Faltys et al. · 2013 [cited by applicant]
US 8634923B2 · Sharpee et al. · 2014 [cited by applicant]
US 8639345B2 · Eipper et al. · 2014 [cited by applicant]
US 8691877B2 · Yun et al. · 2014 [cited by applicant]
US 8700167B2 · Sabel · 2014 [cited by applicant]
US 8725266B2 · Olson et al. · 2014 [cited by applicant]
US 8731683B2 · Lindenthaler · 2014 [cited by applicant]
US 8734513B2 · Wu et al. · 2014 [cited by applicant]
US 8771349B2 · Schachar · 2014 [cited by applicant]
US 8788041B2 · Yun et al. · 2014 [cited by applicant]
US 8801942B2 · Scorsone et al. · 2014 [cited by applicant]
US 8824156B2 · Tai et al. · 2014 [cited by applicant]
US 8852290B2 · Rowley et al. · 2014 [cited by applicant]
US 8864805B2 · Deisseroth et al. · 2014 [cited by applicant]
US 8868202B2 · Della Santina et al. · 2014 [cited by applicant]
US 8903495B2 · Greenberg et al. · 2014 [cited by applicant]
US 8909340B2 · Yun · 2014 [cited by applicant]
US 8918186B2 · Tiedtke · 2014 [cited by applicant]
US 8918188B2 · Tiedtke · 2014 [cited by applicant]
US 8972004B2 · Simon et al. · 2015 [cited by applicant]
US 9002463B2 · Tiedtke · 2015 [cited by applicant]
US 9037251B2 · Narayan et al. · 2015 [cited by applicant]
US 9037252B2 · Tiedtke · 2015 [cited by applicant]
US 9037255B2 · Rocke et al. · 2015 [cited by applicant]
US 9078743B2 · Tai et al. · 2015 [cited by applicant]
US 9079042B2 · Tiedtke et al. · 2015 [cited by applicant]
US 9125734B2 · Keller et al. · 2015 [cited by applicant]
US 9144608B2 · Olson et al. · 2015 [cited by applicant]
US 9162060B2 · Wrobel et al. · 2015 [cited by applicant]
US 9162061B2 · Barnes · 2015 [cited by applicant]
US 9180309B2 · Nirenberg et al. · 2015 [cited by applicant]
US 9186523B1 · Zolli · 2015 [cited by applicant]
US 9187745B2 · Deisseroth et al. · 2015 [cited by applicant]
US 9199080B2 · Gekeler et al. · 2015 [cited by applicant]
US 9220634B2 · Nirenberg · 2015 [cited by applicant]
US 9220894B1 · Zhu · 2015 [cited by applicant]
US 9233026B2 · Ziemeck et al. · 2016 [cited by applicant]
US 9233258B2 · Simon et al. · 2016 [cited by applicant]
US 9242067B2 · Shore et al. · 2016 [cited by applicant]
US 9302103B1 · Nirenberg · 2016 [cited by applicant]
US 9322713B2 · Narayan et al. · 2016 [cited by applicant]
US 9326887B2 · Yun · 2016 [cited by applicant]
US 9339650B2 · Rezai et al. · 2016 [cited by applicant]
US 9345568B2 · Cho et al. · 2016 [cited by applicant]
US 9370348B2 · Tally et al. · 2016 [cited by applicant]
US 9381355B2 · Chraiche et al. · 2016 [cited by applicant]
US 9403001B2 · Simon et al. · 2016 [cited by applicant]
US 9452289B2 · Chichilnisky et al. · 2016 [cited by applicant]
US 9456836B2 · Boling et al. · 2016 [cited by applicant]
US 9468760B1 · Lin · 2016 [cited by applicant]
US 9498380B2 · Berdahl et al. · 2016 [cited by applicant]
US 9630013B2 · Bachinski et al. · 2017 [cited by applicant]
US 9636212B2 · Tiedtke et al. · 2017 [cited by applicant]
US 9682232B2 · Shore et al. · 2017 [cited by applicant]
US 9687652B2 · Franke et al. · 2017 [cited by applicant]
US 9697746B2 · Barnes et al. · 2017 [cited by applicant]
US 9737710B2 · Fan · 2017 [cited by applicant]
US 9737711B2 · Twyford et al. · 2017 [cited by applicant]
US 9789312B2 · Fukuma et al. · 2017 [cited by applicant]
US 9795787B2 · Cho et al. · 2017 [cited by applicant]
US 9821003B2 · Yun · 2017 [cited by applicant]
US 9821159B2 · Ackermann et al. · 2017 [cited by applicant]
US 9844459B2 · Badawi · 2017 [cited by applicant]
US 9867988B2 · Fink et al. · 2018 [cited by applicant]
US 9884180B1 · Ho et al. · 2018 [cited by applicant]
US 9895529B2 · Tiedtke · 2018 [cited by applicant]
US 9925373B2 · Nirenberg · 2018 [cited by applicant]
US 9931506B2 · Chung et al. · 2018 [cited by applicant]
US 9937346B2 · Lineaweaver et al. · 2018 [cited by applicant]
US 9950153B2 · Wagner et al. · 2018 [cited by applicant]
US 9956425B2 · Peyman · 2018 [cited by applicant]
US 9962540B2 · Picaud et al. · 2018 [cited by applicant]
US 9962558B2 · Peyman · 2018 [cited by applicant]
US 9980388B2 · Tai et al. · 2018 [cited by applicant]
US 9990861B2 · Chichilnisky et al. · 2018 [cited by applicant]
US 10010364B2 · Harrington · 2018 [cited by applicant]
US 10071251B2 · Bachinski et al. · 2018 [cited by applicant]
US 10112048B2 · Franke et al. · 2018 [cited by applicant]
US 10129647B2 · Seo et al. · 2018 [cited by applicant]
US 10347050B1 · Wang et al. · 2019 [cited by applicant]
US 11035118B2 · Gamarekian et al. · 2021 [cited by applicant]
US 20030158588A1 · Rizzo et al. · 2003 [cited by applicant]
US 20030233135A1 · Yee · 2003 [cited by applicant]
US 20030233137A1 · Paul, Jr. · 2003 [cited by applicant]
US 20040106965A1 · Chow · 2004 [cited by applicant]
US 20040176820A1 · Paul, Jr. · 2004 [cited by applicant]
US 20050004625A1 · Chow · 2005 [cited by applicant]
US 20050049578A1 · Tu et al. · 2005 [cited by applicant]
US 20050137649A1 · Paul, Jr. · 2005 [cited by applicant]
US 20060142818A1 · Chow et al. · 2006 [cited by applicant]
US 20070093877A1 · Beecham et al. · 2007 [cited by applicant]
US 20070179564A1 · Harold · 2007 [cited by applicant]
US 20080171929A1 · Katims · 2008 [cited by applicant]
US 20080194531A1 · Steer et al. · 2008 [cited by applicant]
US 20090217938A1 · Rabe et al. · 2009 [cited by applicant]
US 20090287276A1 · Greenberg et al. · 2009 [cited by applicant]
US 20110081333A1 · Shantha et al. · 2011 [cited by applicant]
US 20120123501A1 · Greenberg et al. · 2012 [cited by applicant]
US 20130053733A1 · Korb et al. · 2013 [cited by applicant]
US 20130066396A1 · Gekeler et al. · 2013 [cited by applicant]
US 20130184782A1 · Eipper et al. · 2013 [cited by applicant]
US 20140257433A1 · Ackermann et al. · 2014 [cited by applicant]
US 20140277435A1 · Gefen · 2014 [cited by applicant]
US 20140324147A1 · Wagner · 2014 [cited by applicant]
US 20150039067A1 · Greenberg et al. · 2015 [cited by applicant]
US 20150209174A1 · Abreu · 2015 [cited by applicant]
US 20160051439A1 · Brown et al. · 2016 [cited by applicant]
US 20160317474A1 · Aung et al. · 2016 [cited by applicant]
US 20160374594A1 · Garcia Molina · 2016 [cited by examiner]
US 20170266445A1 · O'Clock · 2017 [cited by applicant]
US 20180064935A1 · Leonhardt et al. · 2018 [cited by applicant]
US 20180185651A1 · Astrom · 2018 [cited by examiner]
US 20180228237A1 · Zhang et al. · 2018 [cited by applicant]
US 20180318585A1 · Pfeifer · 2018 [cited by applicant]
US 20180318586A1 · Salazar · 2018 [cited by applicant]
US 20190143116A1 · Mowery et al. · 2019 [cited by applicant]
US 20190223747A1 · Chou · 2019 [cited by applicant]
US 20200391029A1 · Mullins et al. · 2020 [cited by applicant]
CN 1096460A · 1994 [cited by applicant]
DE 202012003100U1 · 2012 [cited by applicant]
EP 1985332A1 · 2008 [cited by applicant]
GB 2246709A · 1992 [cited by applicant]
WO 2006086452A1 · 2006 [cited by applicant]
WO 2013124141A1 · 2013 [cited by applicant]
WO 2015095257A2 · 2015 [cited by applicant]
WO 2016089751A1 · 2016 [cited by applicant]
WO WO2017048731A1 · 2017 [cited by examiner]
WO 2017064500A1 · 2017 [cited by applicant]
WO 2018013835A1 · 2018 [cited by applicant]
WO WO2018089506A1 · 2018 [cited by examiner]
WO 2018129351A1 · 2018 [cited by applicant]
WO 2018208009A1 · 2018 [cited by applicant]
Chlaihawi et al; “Development of Printed and Flexible Dry ECG Electrodes”, Sensing and Bio-Sensing Research, vol. 20, pp. 9-15, 2018. [cited by applicant]
2019 World Congress Eye and Chip Speaker Abstracts, pp. 20-54, 2019. [cited by applicant]
Gall et al; Alternating Current Stimulation for Vision Restoration after Optic Nerve Damage: A Randomized Clinical Trial, PLOS One, pp. 1-13, 2016, accessed Nov. 12, 2018. [cited by applicant]
Chow et al; “The Artificial Silicon Retina in Retinitis Pigmentosa Patients”, Trans Am Ophthalmol Soc., vol. 108, pp. 120-154, 2010. [cited by applicant]
Dawson et al; “Improved Electrode for Electroretinography,” Invest. Ophthalmol. Visual Sci. vol. 8, No. 9, pp. 988-991, Sep. 1979, accessed on May 2, 2019. [cited by applicant]
Diagnosys DTL Brochure, Diagnosys, LLC, 2016, Accessed Nov. 20, 2017. [cited by applicant]
DTL Installation, Diagnosys LLC, Accessed Oct. 6, 2020. [cited by applicant]
Bittner et al; “Longevity of Visual Improvements following Transcorneal Electrical Stimulation and Efficacy of Retreatment in Three Individuals with Retinitis Pigmentosa”, Graefe's Archive for Clinical and Experimental … [cited by applicant]
H110002B Summary of Safety and Probable Benefits, Second Sight Medical Products Inc., issued Dec. 11, 2001. [cited by applicant]
H110002C Second Sight Manuals, Second Sight Medical Products Inc., 2013. [cited by applicant]
Naycheva et al; Phosphene Thresholds Elicited by Trasncorneal Electrical Stimulation in Healthy Subjects and Patients with Retinal Disease, Investigative Ophthamology and Visual Science, vol. 53, No. 12, pp. 7440-7448, … [cited by applicant]
Schatz et al; “Transcorneal Electrical Stimulation for Patients with Retinitis Pigmentosa: A Prospective Randomized, Sham-Controlled Follow-Up Study Over 1 Year”, Investigative Ophthalmology and Visual Science, vol. 58,… [cited by applicant]
Scyfix SF700 Manual, Instructions for Use, pp. 1-28, Scyfix LLC. [cited by applicant]
Stauffer et al; “Skin Conformal Polymer Electrodes for Clinical ECG and EEG Recordings,” Advanced Healthcare Materials pp. 1-10, 2018. [cited by applicant]
Manthey et al; “Using Electrical Stimulation to Enhance the Efficacy of Cell Transplantation Therapies for Neurodegenerative Retinal Diseases: Concepts, Challenges, and Future Perspectives”, Cell Transplantation, vol. 2… [cited by applicant]
Invite to Pay Additional Fees dated Dec. 17, 2019 for International Application No. PCT/US2019/054028. [cited by applicant]
International search Report and Written Opinion dated Jul. 10, 2020 for International Application No. PCT/US2020/027438. [cited by applicant]
Invite to Pay Additional Fees dated Aug. 31, 2020 for International Application No. PCT/US2020/037458. [cited by applicant]
Invite to Pay Additional Fees dated Feb. 14, 2020 for International Application No. PCT/US2019/063580. [cited by applicant]